Article Details

FDA OKs Trial of Investigational DM1 Therapy

Retrieved on: 2021-08-03 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

FDA OKs Trial of Investigational DM1 Therapy. View article details on hiswai:

Excerpt

DM1 is caused by mutations in the DMPK gene that result in cells making a toxic, abnormally long mRNA (messenger RNA, an intermediate molecule ...

Article found on: musculardystrophynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up